A Case of Reversible Infantile Respiratory Chain Deficiency Presenting With Hypotonia, Hyperammonemia, and Failure to Thrive. 2019

Jessenia C Guerrero, and Helio Pedro, and Sarah Parisotto, and Debra Heller, and Ada Baisre-de Leon
Department of Pathology, Immunology and Laboratory Medicine, Rutgers-New Jersey Medical School, Newark, New Jersey.

Reversible infantile respiratory chain deficiency, previously termed reversible infantile cytochrome c oxidase (COX) deficiency myopathy, is a rare mitochondrial disorder that is characterized by severe hypotonia and generalized muscle weakness in infancy that is associated with lactic acidosis. Affected infants will spontaneously recover, if they survive the first months of life. Here, we present the case of a 4-week-old girl who initially presented with hyperammonemia, hypotonia, and failure to thrive, for which she was referred for genetic evaluation. After several tests, a distinct genetic syndrome could not be identified and she continued to deteriorate. A muscle biopsy was performed and demonstrated severe mitochondrial myopathy with abundant COX-negative fibers. Ultrastructural abnormalities of the mitochondria, diagnostic of mitochondrial myopathy, were identified on electron microscopy. Molecular studies revealed the classic homoplasmic disease causing mutation, m.14674 T>C in the MT-TE gene, associated with reversible COX deficiency. Although hyperammonemia is an unusual presentation for mitochondrial myopathies, specifically reversible infantile respiratory chain deficiency, it should be included in the list of possible presenting symptoms for this condition.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D009123 Muscle Hypotonia A diminution of the skeletal muscle tone marked by a diminished resistance to passive stretching. Flaccid Muscle Tone,Hypotonia,Decreased Muscle Tone,Floppy Muscles,Hypomyotonia,Hypotony, Muscle,Muscle Flaccidity,Muscle Tone Atonic,Muscle Tone Poor,Muscular Flaccidity,Muscular Hypotonia,Neonatal Hypotonia,Unilateral Hypotonia,Flaccidity, Muscle,Flaccidity, Muscular,Floppy Muscle,Hypotonia, Muscle,Hypotonia, Muscular,Hypotonia, Neonatal,Hypotonia, Unilateral,Hypotonias, Neonatal,Hypotonias, Unilateral,Muscle Hypotony,Muscle Tone Atonics,Muscle Tone, Decreased,Muscle Tone, Flaccid,Muscle, Floppy,Muscles, Floppy,Muscular Flaccidities,Neonatal Hypotonias,Tone Atonic, Muscle,Tone Poor, Muscle
D005183 Failure to Thrive A condition of substandard growth or diminished capacity to maintain normal function. Thrive, Failure to
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D022124 Hyperammonemia Elevated level of AMMONIA in the blood. It is a sign of defective CATABOLISM of AMINO ACIDS or ammonia to UREA.
D030401 Cytochrome-c Oxidase Deficiency A disease that results from a congenital defect in ELECTRON TRANSPORT COMPLEX IV. Defects in ELECTRON TRANSPORT COMPLEX IV can be caused by mutations in the SURF1, SCO2, COX10, or SCO1 genes. ELECTRON TRANSPORT COMPLEX IV deficiency caused by mutation in SURF1 manifests itself as LEIGH DISEASE; that caused by mutation in SCO2 as fatal infantile cardioencephalomyopathy; that caused by mutation in COX10 as tubulopathy and leukodystrophy; and that caused by mutation in SCO1 as early-onset hepatic failure and neurologic disorder. (from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim, MIM#220110, May 17, 2001) Complex IV Deficiency,Cox Deficiency,Cytochrome C Oxidase Deficiency,Cytochrome Oxidase Deficiency,Deficiency, Cytochrome-c Oxidase,Mitochondrial Complex IV Deficiency,Complex IV Deficiencies,Cox Deficiencies,Cytochrome Oxidase Deficiencies,Cytochrome-c Oxidase Deficiencies,Deficiencies, Complex IV,Deficiencies, Cox,Deficiencies, Cytochrome Oxidase,Deficiencies, Cytochrome-c Oxidase,Deficiency, Complex IV,Deficiency, Cox,Deficiency, Cytochrome Oxidase,Deficiency, Cytochrome c Oxidase,Oxidase Deficiencies, Cytochrome,Oxidase Deficiencies, Cytochrome-c,Oxidase Deficiency, Cytochrome,Oxidase Deficiency, Cytochrome-c

Related Publications

Jessenia C Guerrero, and Helio Pedro, and Sarah Parisotto, and Debra Heller, and Ada Baisre-de Leon
January 2012, The American journal of case reports,
Jessenia C Guerrero, and Helio Pedro, and Sarah Parisotto, and Debra Heller, and Ada Baisre-de Leon
December 1978, The Journal of pediatrics,
Jessenia C Guerrero, and Helio Pedro, and Sarah Parisotto, and Debra Heller, and Ada Baisre-de Leon
December 2010, Annals of neurology,
Jessenia C Guerrero, and Helio Pedro, and Sarah Parisotto, and Debra Heller, and Ada Baisre-de Leon
August 2021, NeoReviews,
Jessenia C Guerrero, and Helio Pedro, and Sarah Parisotto, and Debra Heller, and Ada Baisre-de Leon
October 2021, European journal of medical genetics,
Jessenia C Guerrero, and Helio Pedro, and Sarah Parisotto, and Debra Heller, and Ada Baisre-de Leon
July 2000, Journal of inherited metabolic disease,
Jessenia C Guerrero, and Helio Pedro, and Sarah Parisotto, and Debra Heller, and Ada Baisre-de Leon
December 2020, The EMBO journal,
Jessenia C Guerrero, and Helio Pedro, and Sarah Parisotto, and Debra Heller, and Ada Baisre-de Leon
November 2013, Clinical pediatrics,
Jessenia C Guerrero, and Helio Pedro, and Sarah Parisotto, and Debra Heller, and Ada Baisre-de Leon
October 2011, Journal of medical genetics,
Jessenia C Guerrero, and Helio Pedro, and Sarah Parisotto, and Debra Heller, and Ada Baisre-de Leon
January 2016, Pediatrics in review,
Copied contents to your clipboard!